We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (21)
- Safety monitoring and information (13)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
Collection content
113 result(s) found, displaying 101 to 110
-
User guideSteps to register a new fixed combination medicine.
-
FormsSubmission dossier checklist for prescription medicines
-
FormsCertified product details (CPD) - Chemical prescription medicines
-
Medicine shortage alertsConcerta modified-release tablets will remain in shortage at various times until the end of 2026
-
Medicine shortage alertsAll strengths of the Mounjaro vial presentation are discontinued but the Mounjaro KwikPen is available in the same strengths.
-
Medicine shortage alertsClinical guidance for prescribers during the shortages is available.
-
Medicine shortage alertsWe have approved overseas-registered substitutes for Pegasys 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
-
Medicine shortage alertsA new 3 mL presentation of Ozempic 0.25 mg/0.5 mg pre-filled pen is now available to replace the 1.5 mL presentation, which is being discontinued.
-
Medicine shortage alertsVarious brands of metformin hydrochloride 1000 mg immediate-release tablets are in shortage.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.